342 related articles for article (PubMed ID: 30558460)
1. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.
Nyström A; Mörse H; Nordlöf H; Wiebe K; Artman M; Øra I; Giwercman A; Henic E; Elfving M
Acta Oncol; 2019 Feb; 58(2):218-224. PubMed ID: 30558460
[TBL] [Abstract][Full Text] [Related]
2. Interactions between serum FSH, inhibin B and antral follicle count in the decline of serum AMH during the menstrual cycle in late reproductive age.
Robertson DM; Lee CH; Baerwald A
Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00172. PubMed ID: 33855196
[TBL] [Abstract][Full Text] [Related]
3. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.
Knauff EA; Eijkemans MJ; Lambalk CB; ten Kate-Booij MJ; Hoek A; Beerendonk CC; Laven JS; Goverde AJ; Broekmans FJ; Themmen AP; de Jong FH; Fauser BC;
J Clin Endocrinol Metab; 2009 Mar; 94(3):786-92. PubMed ID: 19066296
[TBL] [Abstract][Full Text] [Related]
4. Ovarian Reserve Markers in Premature Ovarian Insufficiency: Within Different Clinical Stages and Different Etiologies.
Jiao X; Meng T; Zhai Y; Zhao L; Luo W; Liu P; Qin Y
Front Endocrinol (Lausanne); 2021; 12():601752. PubMed ID: 33815272
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
Zhang F; Liu XL; Rong N; Huang XW
J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
[TBL] [Abstract][Full Text] [Related]
6. Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.
Ocal P; Sahmay S; Cetin M; Irez T; Guralp O; Cepni I
J Assist Reprod Genet; 2011 Dec; 28(12):1197-203. PubMed ID: 21882017
[TBL] [Abstract][Full Text] [Related]
7. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
8. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome.
Eldar-Geva T; Ben-Chetrit A; Spitz IM; Rabinowitz R; Markowitz E; Mimoni T; Gal M; Zylber-Haran E; Margalioth EJ
Hum Reprod; 2005 Nov; 20(11):3178-83. PubMed ID: 16113044
[TBL] [Abstract][Full Text] [Related]
9. Anti-Müllerian Hormone and Ovarian Morphology in Women With Isolated Hypogonadotropic Hypogonadism/Kallmann Syndrome: Effects of Recombinant Human FSH.
Bry-Gauillard H; Larrat-Ledoux F; Levaillant JM; Massin N; Maione L; Beau I; Binart N; Chanson P; Brailly-Tabard S; Hall JE; Young J
J Clin Endocrinol Metab; 2017 Apr; 102(4):1102-1111. PubMed ID: 28324034
[TBL] [Abstract][Full Text] [Related]
10. Impact of cancer therapies on ovarian reserve.
Gracia CR; Sammel MD; Freeman E; Prewitt M; Carlson C; Ray A; Vance A; Ginsberg JP
Fertil Steril; 2012 Jan; 97(1):134-40.e1. PubMed ID: 22137491
[TBL] [Abstract][Full Text] [Related]
11. Can Inhibin B Reflect Ovarian Reserve of Healthy Reproductive Age Women Effectively?
Wen J; Huang K; Du X; Zhang H; Ding T; Zhang C; Ma W; Zhong Y; Qu W; Liu Y; Li Z; Deng S; Luo A; Jin Y; Zhang J; Wang S
Front Endocrinol (Lausanne); 2021; 12():626534. PubMed ID: 33935966
[TBL] [Abstract][Full Text] [Related]
12. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
13. [Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer].
He Y; Xia R; Chen X; Ye D; Tang Y; Li P; Niu J; Chen S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):216-20. PubMed ID: 23443775
[TBL] [Abstract][Full Text] [Related]
14. Correlation between sonographic and endocrine markers of ovarian aging as predictors for late menopausal transition.
Yang YS; Hur MH; Kim SY; Young K
Menopause; 2011 Feb; 18(2):138-45. PubMed ID: 21341396
[TBL] [Abstract][Full Text] [Related]
15. Serum anti-müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles.
Sahmay S; Demirayak G; Guralp O; Ocal P; Senturk LM; Oral E; Irez T
J Assist Reprod Genet; 2012 Jul; 29(7):589-95. PubMed ID: 22492221
[TBL] [Abstract][Full Text] [Related]
16. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
17. Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency.
Cai Y; Zhang Q; Yu K; Wang Q
Biomed Res Int; 2022; 2022():3878359. PubMed ID: 36277874
[TBL] [Abstract][Full Text] [Related]
18. The status and comparison of ovarian reserve between fertile and infertile healthy Chinese women of reproductive age.
Zhou SJ; Sun TC; Song LL; Yang M; Sun XP; Tian L
Medicine (Baltimore); 2021 Apr; 100(17):e25361. PubMed ID: 33907092
[TBL] [Abstract][Full Text] [Related]
19. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception.
Bentzen JG; Forman JL; Pinborg A; Lidegaard Ø; Larsen EC; Friis-Hansen L; Johannsen TH; Nyboe Andersen A
Reprod Biomed Online; 2012 Dec; 25(6):612-9. PubMed ID: 23069740
[TBL] [Abstract][Full Text] [Related]
20. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
Alebic MŠ; Stojanovic N; Dewailly D
Hum Reprod; 2018 Jun; 33(6):1141-1148. PubMed ID: 29688494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
